Skip to main content

St. Louis-born Galera Therapeutics goes public with $60M IPO

The biotechnology company, which was started in St. Louis and continues to operate here, is developing treatments to reduce the harmful effect of radiation therapy.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.